BioCentury
ARTICLE | Company News

Medicenna goes public

March 17, 2017 4:25 PM UTC

Cancer company Medicenna Therapeutics Inc. went public via the acquisition of Canadian capital pool company A2 Acquisition Corp. A2 shareholders received one share in the newco for every 14 A2 shares held. Prior to the deal, the company raised C$4 million ($3 million) through the sale of 2 million shares at C$2 in a private placement led by Richardson GMP, with participation from Bloom Burton...

BCIQ Company Profiles

Medicenna Therapeutics Corp.